Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Phase II Trial of BIBW 2992 (Afatinib) in Genetically Pre-screened Cancers With EGFR and/or HER2 Gene Amplification
afatinib
1200.26
NCT00748709
Neoplasms
Phase 2
 
July 2014

Powered by ideaPoint, Inc.